USD 153.93 million
Malignant Mesothelioma Market Size, Share, Growth Analysis, By Application(Hospital Pharmacies, Retail Pharmacies, Oncology Centers, Others), By Type(Oral, Parenteral), By Region - Industry Forecast 2025-2032
Report ID:
SQMIG35A2772 |
Region:
Global |
Published Date: February, 2024
Pages:
157
|Tables:
63
|Figures:
75
Malignant Mesothelioma Market Insights
Malignant Mesothelioma Market size was valued at USD 162.7 Million in 2023 and is poised to grow from USD 171.97 Million in 2024 to USD 267.96 Million by 2032, growing at a CAGR of 5.7% during the forecast period (2025-2032).
Mesothelioma patient advocacy groups and support networks play a vital role in the global fight against this cancer. These organizations contribute to increased awareness, facilitate early diagnosis, and provide essential support for individuals affected by mesothelioma. Through their advocacy, education, and outreach, these groups play an indispensable role in improving patient care and ensuring that those impacted by the disease receive the assistance and resources they require on their challenging journey.
Market snapshot - 2025-2032
Global Market Size
Largest Segment
Fastest Growth
retail pharmacies
Growth Rate
5.7% CAGR
Global Malignant Mesothelioma Market ($ Bn)
Global Malignant Mesothelioma Market By Application ($ Bn)
To get more reports on the above market click here to Buy The Report
Malignant Mesothelioma Market Segmental Analysis
The global malignant mesothelioma market is segmented into three major segments i.e. by type, application, region. Based on type the market is segmented as, oral, parenteral. Based on application the market is segmented as, hospital pharmacies, retail pharmacies, oncology centers, other. Based on region the market is segmented as, North America, Europe, Asia-Pacific, MEA, and Latin America.
Analysis by Application
Hospital pharmacies segment are responsible for dispensing and managing medications used in the treatment of malignant mesothelioma. They ensure that patients receive the appropriate chemotherapy drugs, pain management medications, and other therapeutics as prescribed by oncologists and healthcare providers.
Retail pharmacies segment play a role in the global malignant mesothelioma market by providing essential prescription medications related to mesothelioma treatment. While these retail establishments may not typically stock highly specialized chemotherapy drugs specific to cancer treatment, they serve a critical function by offering supportive medications that contribute to the overall well-being of mesothelioma patients.
Analysis by Type
Oral segment does not typically correspond to a specific category or sector within the market. Instead, it appears to be a misinterpretation or misunderstanding. Malignant mesothelioma primarily affects the lining of the lungs, abdomen, and, in rare cases, the heart. The diagnosis and treatment of this aggressive cancer primarily involve multidisciplinary medical specialties, including oncology, radiology, surgery, and pathology, among others.
Parental segment is not typically associated with mesothelioma diagnosis or treatment. Instead, it might be a misunderstanding or a term not commonly used in this specific medical field. Malignant mesothelioma primarily involves the lining of the lungs, abdomen, or, rarely, the heart, and the treatment approach typically includes various medical specialties, such as oncology, radiology, surgery, and pathology, among others.
Global Malignant Mesothelioma Market By Type
To get detailed analysis on other segments, Request For Free Sample Report
Malignant Mesothelioma Market Regional Insights
North America, with a specific focus on the United States, has long been recognized as the dominant region in the global malignant mesothelioma market. The United States has witnessed a notable concentration of mesothelioma cases owing to historical asbestos exposure prevalent across a range of industries, including construction, shipbuilding, and manufacturing.
The Asia-Pacific region has experienced a notable increase in the incidence of malignant mesothelioma, a trend that raises significant concerns. This surge in cases is primarily attributed to historical asbestos use and ongoing asbestos exposure within various industries across the region.
Global Malignant Mesothelioma Market By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Malignant Mesothelioma Market Dynamics
Drivers
Rise in Advances in Diagnosis
- The rise in advances in diagnostic techniques is a crucial factor driving the identification of malignant mesothelioma cases. Over the years, there have been significant improvements in the methods and tools used for the diagnosis of this cancer. These advances, combined with heightened awareness of the disease among both medical professionals and the general public, have led to earlier detection and diagnosis. As a result, more cases are being reported and diagnosed at an earlier stage.
Restraints
Extended Time to Diagnosis to Hamper the Market
- Malignant mesothelioma is characterized by a notably protracted latency period, frequently extending over several decades, from the initial asbestos exposure to the manifestation of symptoms. This prolonged timeline poses a substantial challenge, as it significantly impedes the early diagnosis and timely intervention for individuals at risk.
Request Free Customization of this report to help us to meet your business objectives.
Malignant Mesothelioma Market Competitive Landscape
The competitive environment of the global malignant mesothelioma market is dynamic and characterized by the presence of a mix of well-established brands, emerging players, and niche producers. Innovation is a key competitive factor. To understand the competitive rivalry, we are comparing the revenue, expenses, resources, product portfolio, region coverage, market share, key initiatives, product launches, and any news related to the malignant mesothelioma market.
Top Player’s Company Profiles
- AstraZeneca
- Bristol-Myers Squibb
- Roche
- Merck
- Novartis
- Pfizer
- Sanofi
- Eli Lilly
- Teva Pharmaceuticals
- Boehringer Ingelheim GmbH
- Mylan
- Fresenius Kabi
- Sun Pharmaceuticals
- Corden Pharma
- Concordia International
- Kyowa Hakko Kirin
- Polaris Pharmaceuticals
- MolMed
- Ono Pharmaceutical
- Nichi-Iko Pharmaceutical
Recent Developments
- In January 2023, Breast Cancer gene 1-associated protein gene, commonly known as BRCA1, and the cyclin-dependent kinase inhibitor 2A (CDKN2A) are two pivotal genes that play a significant role in cancer biology and prognosis. These genes have demonstrated a profound prognostic impact, and their assessment in patient samples is increasingly essential in the field of oncology.
Malignant Mesothelioma Key Market Trends
- The aging population is a significant driver behind the increased incidence of malignant mesothelioma. This cancer is more prevalent among older individuals, and as the global population continues to age, the likelihood of new cases is expected to rise. The extended latency period for mesothelioma, which can be several decades from asbestos exposure, means that those who were exposed to asbestos earlier in life may develop the disease as they grow older.
Malignant Mesothelioma Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
Global malignant mesothelioma market analysis reveals a dynamic marketplace with a number of standout trends and difficulties. The surging demand for treatments for malignant mesothelioma is intrinsically linked to the increasing prevalence of high-risk factors. This trend is expected to persist during the forecast period, playing a pivotal role in the expansion of the global market for malignant mesothelioma treatments. The primary driving force behind this growth is the rising incidence of this aggressive cancer.
| Report Metric | Details |
|---|---|
| Market size value in 2023 | USD 162.7 Million |
| Market size value in 2032 | USD 267.96 Million |
| Growth Rate | 5.7% |
| Base year | 2024 |
| Forecast period | 2025-2032 |
| Forecast Unit (Value) | USD Million |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Malignant Mesothelioma Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Malignant Mesothelioma Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Malignant Mesothelioma Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Malignant Mesothelioma Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Malignant Mesothelioma Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Malignant Mesothelioma Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
